Filter
274
Text search:
Licensed
pharmaceutical
products
Featured
Recommendations
15
New Publications
65
Language
Document type
No document type
112
Studies & Reports
74
Guidelines
43
Manuals
25
Strategic & Response Plan
14
Fact sheets
4
Situation Updates
2
Countries / Regions
Kenya
24
Nigeria
10
South Africa
9
Liberia
7
Ghana
7
Uganda
7
Zimbabwe
7
India
7
Ethiopia
6
Tanzania
6
Sierra Leone
5
Bangladesh
5
Western and Central Europe
5
Philippines
4
Zambia
4
Malawi
4
Botswana
4
Global
4
Senegal
3
Nepal
3
Syria
3
Rwanda
3
Ukraine
3
Eastern Europe and Central Asia
3
Cambodia
2
Indonesia
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
Myanmar / Burma
2
Latin America and the Carribbean
2
United Kingdom
2
Burkina Faso
1
Cameroon
1
Haiti
1
Thailand
1
Sudan
1
Brazil
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Asia
1
Africa
1
Eastern Europe
1
Moldova
1
North America
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
141
Clinical Guidelines
16
Pharmacy & Technologies
11
Public Health
10
Key Resources
7
Women & Child Health
5
Capacity Building
1
Toolboxes
AMR
48
Pharmacy
48
COVID-19
19
Mental Health
8
HIV
6
TB
6
Caregiver
4
NTDs
4
Malaria
4
Ebola & Marburg
3
Conflict
3
Global Health Education
2
Planetary Health
2
Disability
1
Natural Hazards
1
Rapid Response
1
Refugee
1
Health Financing Toolbox
1
NCDs
1
EMCDDA Insights - 11
Accessed: 14.03.2019
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub
...
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-
...
Expanding access to quality health services through task sharing
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people
...
SITUATION ANALYSIS AND RECOMMENDATIONS
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has
...
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A
...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of
...
This guide is available in English, French, Spanish, Russian, Arabic and Chinese
This guide consolidates COVID-19 guidance for human resources for health managers and policy-makers at national, subnational and facility levels to design, manage and preserve the workforce necessary to manage the COVI
...
Revised Edition
